Phanes Therapeutics

Business news, market intelligence, and global industry analysis.

The Latest

Can Southland Holdings, Inc. turn water and data center demand into a cleaner growth story? (NYSE American: SLND)

How are companies like Starfighters Space and Archer Aviation redefining aerospace growth?

Equinor activates ultra-deepwater drilling with the Valaris DS-17 drillship at Raia as Brazil's natural gas supply gap draws international capital.

Equinor (EQNR) activates $9bn Raia drilling campaign in Brazil as deepwater gas race intensifies

Representative image of AI-powered contract review software in a corporate legal workflow, illustrating how Docusign’s new AI contract review assistant could help streamline agreement analysis, redlining, and contract negotiations.

Docusign (NASDAQ: DOCU) pushes deeper into legal workflow automation with AI contract review launch

Phanes Therapeutics’ PT217 receives FDA orphan drug designation for neuroendocrine carcinoma

Phanes Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing oncology treatments, has achieved a significant milestone with…

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

August 18, 2024